Stratevi Company Profile

Background

Overview

Stratevi is a boutique consulting firm specializing in health economics, outcomes research, pricing, and market access within the biotechnology, pharmaceutical, and medical device industries. Established in 2015, the company operates from offices in Santa Monica, California, and Boston, Massachusetts. The name 'Stratevi' reflects its core mission: seamlessly combining strategy and evidence to drive value and ensure optimal patient access to therapies.

Mission and Vision

Stratevi's mission is to partner with life sciences companies to creatively develop and communicate evidence that supports product value, facilitating optimal patient access to therapies. The firm envisions a healthcare landscape where strategic evidence generation and communication lead to improved health outcomes and equitable access to innovative treatments.

Industry Significance

In the rapidly evolving healthcare sector, Stratevi plays a pivotal role by providing specialized consulting services that bridge the gap between clinical development and market access. Its expertise in health economics and outcomes research (HEOR) is crucial for clients navigating complex regulatory environments and demonstrating the value of their products to stakeholders.

Key Strategic Focus

Core Objectives

Stratevi focuses on delivering comprehensive solutions that encompass:

Value Proposition Development: Crafting compelling narratives that articulate the value of clients' products.

Strategic Planning: Guiding clients through evidence generation and market access strategies.

Study Design Recommendations: Advising on optimal study designs to generate robust evidence.

Competitive Simulations: Conducting simulations to anticipate market dynamics and inform strategic decisions.

Areas of Specialization

The firm's specialization includes:

Health Economics and Outcomes Research (HEOR): Evaluating economic and patient-centered outcomes to inform healthcare decisions.

Pricing and Market Access: Developing strategies to optimize product pricing and ensure market entry.

Medical Affairs: Supporting medical teams in evidence dissemination and stakeholder engagement.

Key Technologies Utilized

Stratevi leverages proprietary technologies such as StrateFlow™, a software platform designed to assist HEOR, Medical, and Access teams in project management and stakeholder alignment.

Primary Markets Targeted

The company primarily serves biotechnology, pharmaceutical, and medical device manufacturers, focusing on markets in North America and Europe.

Financials and Funding

Revenue

As of the latest available data, Stratevi's estimated annual revenue is approximately $5.1 million, with an estimated revenue per employee of $155,000.

Funding History

Specific details regarding Stratevi's funding history are not publicly disclosed.

Pipeline Development

As a consulting firm, Stratevi does not have a product pipeline. Instead, it collaborates with clients to develop and communicate evidence supporting their products' value, facilitating market access and adoption.

Technological Platform and Innovation

Proprietary Technologies

Stratevi has developed several proprietary products and services, including:

StrateFlow™: A software platform designed to assist HEOR, Medical, and Access teams in project management and stakeholder alignment.

StrateLaunch™: A service aimed at supporting product launches through strategic planning and evidence generation.

StratePulse®: A tool for monitoring market dynamics and gathering insights to inform strategic decisions.

StrateReview™: A service providing comprehensive reviews of existing evidence to identify gaps and opportunities.

StrateVision®: A platform offering visual analytics to support evidence communication.

StratePlay®: An interactive training solution designed to enhance team capabilities in evidence generation and communication.

Scientific Methodologies

The firm employs advanced scientific methodologies, including:

Economic Modeling: Developing cost-effectiveness and budget impact models to assess the economic value of healthcare interventions.

Real-World Evidence Generation: Conducting retrospective database analyses and prospective outcome studies to gather real-world data.

Health Technology Assessment (HTA) Strategy: Formulating strategies to navigate HTA processes and optimize product positioning.

Leadership Team

Executive Profiles

Josh Epstein, PhD: Chief Executive Officer, Santa Monica.

Josephine Li-McLeod, RPh, PhD: Chief Strategy Officer, Boston.

Matt Sussman, MA: Chief Research Officer, Boston.

Daniele Severi Bruni, MS: Chief Access Officer, Santa Monica.

Tim Brown: Chief Operating Officer, Colorado.

Sean Brugger, PhD: Senior Principal, Santa Monica.

Diane Ito, MA: Senior Director, Santa Monica.

Jen Benner: Director, Florida.

Alex Ellis, PhD: Director, Boston.

Samira Massachi, PharmD, MA: Director, Santa Monica.

Jesse Ortendahl, MS: Director, Boston.

Mihail Samnaliev, PhD: Director, Boston.

Rebekah Zincavage, PhD: Director, Boston.

Brad Padilla, MPH: Associate Director, Texas.

Roy Arguello, MS: Senior Manager, Washington.

Jackie Lee: Senior Manager, Santa Monica.

Kristin Mickle, MPH: Senior Manager, Maryland.

Yi Pan, MD, PhD: Senior Manager, Illinois.

Nick Adair, MS: Manager, Boston.

Chris Bly: Manager, Indiana.

Maggie O'Grady, MA: Manager, Boston.

Laura Cianciolo, MPA: Senior Research Associate, Boston.

Madelaine Cookson: Senior Research Associate, Santa Monica.

Lauren Do, MS: Senior Research Associate, Boston.

Ava Maurillo: Research Associate, Boston.

Felicia Lewinstein, MA: Operations Director, Santa Monica.

William Mendoza, MA: Operations Senior Manager, Santa Monica.

Jake Pistotnik, MS: AI Manager, Santa Monica.

Kristina Haygood: Operations, Texas.

Leadership Changes

As of the latest available information, there have been no recent significant changes or appointments within Stratevi's leadership team.

Competitor Profile

Market Insights and Dynamics

The health economics and outcomes research (HEOR) consulting market is experiencing significant growth, driven by increasing demand for evidence-based decision-making in healthcare. Factors such as regulatory requirements, payer scrutiny, and the need for demonstrating product value contribute to this trend.

Competitor Analysis

Key competitors in the HEOR and market access consulting space include:

ICON plc: A global provider of outsourced development and commercialisation services to the pharmaceutical, biotechnology, and medical device industries.

IQVIA: Offers advanced analytics, technology solutions, and contract research services.

Parexel International: Provides comprehensive drug development and regulatory consulting services.

Evidera: Specializes in evidence synthesis, modeling, and real-world evidence generation.

These firms offer a range of services overlapping with Stratevi's offerings, contributing to a competitive landscape that emphasizes innovation, client relationships, and specialized expertise.

Strategic Collaborations and Partnerships

Stratevi has developed proprietary products and services, including StrateFlow™, StrateLaunch™, StratePulse®, StrateReview™, StrateVision®, and StratePlay®, to enhance its service offerings and client engagement.

Operational Insights

Stratevi continues to innovate and adapt to the evolving healthcare landscape through its proprietary technologies and strategic focus areas. The firm's deep expertise in HEOR, pricing, and market access, coupled with its dedicated team of industry experts, positions it as a key player in supporting life sciences companies' success.